EUVIMEDEUVIMED entdecken
Crossref

Nanotherapeutics-mediated tolerogenic induction for enabling adeno-associated virus vector gene therapy re-administration by overcoming anti-drug antibodies

Yubo Liu, Fangming Liang, Rui Zhang, Chengcheng Tang, Xin Li, Yongjun Wang, Zhonggui He, Hongzhuo Liu

Materials Horizons · 2025

DOI: 10.1039/d5mh00203f ↗

Kurz gefasst

Fachartikel in der Zeitschrift Materials Horizons, 2025. Verfasst von Yubo Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, 110016, P. R. China. liuhongzhuo@syphu.edu.cn. Hauptthemen laut MEDLINE: Dependovirus, Genetic Therapy, Genetic Vectors, Immune Tolerance. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 64 Literaturangaben. Gefördert von: Shenyang Municipal Bureau of Science and Technology, Department of Education of Liaoning Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Utilizing co-assembled nanoparticles composed of lipidated rapamycin and itaconic acid to enable repeatable administration of recombinant adeno-associated virus vectors by eliminating the formation of anti-drug antibodies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DependovirusGenetic TherapyGenetic VectorsImmune ToleranceAnimalsHumansMiceSirolimusMice, Inbred C57BLNanoparticles

Substanzen

Sirolimus

Autor:innen und Institutionen

  • Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, 110016, P. R. China. liuhongzhuo@syphu.edu.cn.
  • Shenyang Sunshine Pharmaceuticals Co., Ltd., Shenyang, 110016, P. R. China.
  • Department of Respiratory Medicine, First Affiliated Hospital of Jinzhou Medical University, Jinzhou, 121001, P. R. China.

Förderung

  • Shenyang Municipal Bureau of Science and Technology
  • Department of Education of Liaoning Province

Zitieren

APA

Liu, Y., Liang, F., Zhang, R., Tang, C., Li, X., Wang, Y., He, Z., & Liu, H. (2025). Nanotherapeutics-mediated tolerogenic induction for enabling adeno-associated virus vector gene therapy re-administration by overcoming anti-drug antibodies. Materials Horizons. https://doi.org/10.1039/d5mh00203f

Vancouver

Liu Y, Liang F, Zhang R, Tang C, Li X, Wang Y, et al. Nanotherapeutics-mediated tolerogenic induction for enabling adeno-associated virus vector gene therapy re-administration by overcoming anti-drug antibodies. Materials Horizons. 2025. doi:10.1039/d5mh00203f

BibTeX
@article{Liu2025,
  author = {Liu, Yubo and Liang, Fangming and Zhang, Rui and Tang, Chengcheng and Li, Xin and Wang, Yongjun and He, Zhonggui and Liu, Hongzhuo},
  title = {Nanotherapeutics-mediated tolerogenic induction for enabling adeno-associated virus vector gene therapy re-administration by overcoming anti-drug antibodies},
  journal = {Materials Horizons},
  year = {2025},
  doi = {10.1039/d5mh00203f}
}
Kostenlos starten →